论文部分内容阅读
乙型病毒性肝炎(hepatitisbvirus,HBV),简称乙肝,在甲、乙、丙、丁、戊型肝炎中最为严重的一种.他一直是我国“八五”、“九五”、“十五”重点医疗科研攻关项目.众所周知,乙肝危害已成为一种严重的世界性疾病,全球大约有20多亿人感染过HBV,其中约有4亿人为慢性感染.WHO已将HBV感染列为世界第九死亡原因,每年全世界死亡人数约30万.我国是HBV感染高发区,有50-70%的人感染过HBV,约有1.7亿人(占全国人口的十分之一还要多)是HBsAg携带者.我国现患乙肝者约3000万,其中60%以上为慢性乙肝患者.可见乙肝患病者之多,对人类危害之大.为了让人们了解乙肝,本文从HBV的感染,发病、转归(慢性乙肝,肝硬化、肝癌)和药物治疗进行系统的介绍和讨论.
Hepatitis B virus (HBV), referred to as hepatitis B for short, is one of the most serious forms of hepatitis A, B, C, D and E. He has been one of the most important diseases in China during the “Eighth Five-Year Plan”, “Ninth Five-Year Plan” It is well known that hepatitis B harm has become a serious worldwide disease and that there are about 2 billion people infected with HBV in the world and about 400 million people are chronic infection.WHO has listed HBV infection as the world’s first Nine causes of death, the annual death toll of about 300000. China is a high incidence of HBV infection, 50-70% of people infected with HBV, about 170 million people (one tenth of the national population even more) is HBsAg carriers.China now suffering from hepatitis B about 30 million, of which more than 60% of patients with chronic hepatitis B. Can be seen as many patients with hepatitis B, human harm .In order to make people understand hepatitis B, this article from HBV infection, incidence, Outcomes (chronic hepatitis B, liver cirrhosis, liver cancer) and drug treatment system introduction and discussion.